223 related articles for article (PubMed ID: 11696064)
1. Chronological ageing and photoageing of the human sebaceous gland.
Zouboulis CC; Boschnakow A
Clin Exp Dermatol; 2001 Oct; 26(7):600-7. PubMed ID: 11696064
[TBL] [Abstract][Full Text] [Related]
2. Loss of mismatch repair proteins in sebaceous gland tumors.
Popnikolov NK; Gatalica Z; Colome-Grimmer MI; Sánchez RL
J Cutan Pathol; 2003 Mar; 30(3):178-84. PubMed ID: 12641777
[TBL] [Abstract][Full Text] [Related]
3. New pharmaceutical concepts for sebaceous gland diseases: implementing today's pre-clinical data into tomorrow's daily clinical practice.
Zampeli VA; Makrantonaki E; Tzellos T; Zouboulis CC
Curr Pharm Biotechnol; 2012 Aug; 13(10):1898-913. PubMed ID: 22250709
[TBL] [Abstract][Full Text] [Related]
4. An association between sebaceous carcinoma and microsatellite instability in immunosuppressed organ transplant recipients.
Harwood CA; Swale VJ; Bataille VA; Quinn AG; Ghali L; Patel SV; Dove-Edwin I; Cerio R; McGregor JM
J Invest Dermatol; 2001 Feb; 116(2):246-53. PubMed ID: 11180000
[TBL] [Abstract][Full Text] [Related]
5. Frequency of microsatellite instability in unselected sebaceous gland neoplasias and hyperplasias.
Kruse R; Rütten A; Schweiger N; Jakob E; Mathiak M; Propping P; Mangold E; Bisceglia M; Ruzicka T
J Invest Dermatol; 2003 May; 120(5):858-64. PubMed ID: 12713593
[TBL] [Abstract][Full Text] [Related]
6. Age-related changes in sebaceous gland activity.
Pochi PE; Strauss JS; Downing DT
J Invest Dermatol; 1979 Jul; 73(1):108-11. PubMed ID: 448169
[TBL] [Abstract][Full Text] [Related]
7. Fordyce granules and hyperplastic mucosal sebaceous glands as distinctive stigmata in Muir-Torre syndrome patients: characterization with reflectance confocal microscopy.
Ponti G; Meschieri A; Pollio A; Ruini C; Manfredini M; Longo C; Mandel VD; Ciardo S; Tomasi A; Giannetti L; Pellacani G
J Oral Pathol Med; 2015 Aug; 44(7):552-7. PubMed ID: 25213213
[TBL] [Abstract][Full Text] [Related]
8. Acne and sebaceous gland function.
Zouboulis CC
Clin Dermatol; 2004; 22(5):360-6. PubMed ID: 15556719
[TBL] [Abstract][Full Text] [Related]
9. Microsatellite instability and expression of hMLH-1 and hMSH-2 in sebaceous gland carcinomas as markers for Muir-Torre syndrome.
Entius MM; Keller JJ; Drillenburg P; Kuypers KC; Giardiello FM; Offerhaus GJ
Clin Cancer Res; 2000 May; 6(5):1784-9. PubMed ID: 10815898
[TBL] [Abstract][Full Text] [Related]
10. Isotretinoin for sebaceous skin lesions in Muir-Torre syndrome: a case report.
Marcusson JA; Bjarnason B; Ros AM
Acta Derm Venereol; 1998 Nov; 78(6):479-80. PubMed ID: 9833060
[No Abstract] [Full Text] [Related]
11. Sebaceous Neoplasms With Rippled, Labyrinthine/Sinusoidal, Petaloid, and Carcinoid-Like Patterns: A Study of 57 Cases Validating Their Occurrence as a Morphological Spectrum and Showing No Significant Association With Muir-Torre Syndrome or DNA Mismatch Repair Protein Deficiency.
Wiedemeyer K; Kyrpychova L; Işikci ÖT; Spagnolo DV; Kutzner H; Rütten A; Fernandez-Figueras MT; Denisjuk N; Suster S; Pavlovsky M; Petersson F; Michal M; Lee J; Kerl K; Kazakov DV
Am J Dermatopathol; 2018 Jul; 40(7):479-485. PubMed ID: 29924747
[TBL] [Abstract][Full Text] [Related]
12. An updated review of the sebaceous gland and its role in health and diseases Part 1: Embryology, evolution, structure, and function of sebaceous glands.
Shamloul G; Khachemoune A
Dermatol Ther; 2021 Jan; 34(1):e14695. PubMed ID: 33354858
[TBL] [Abstract][Full Text] [Related]
13. Loss of fragile histidine triad (FHIT) expression and microsatellite instability in periocular sebaceous gland carcinoma in patients with Muir-Torre syndrome.
Holbach LM; von Moller A; Decker C; Jünemann AG; Rummelt-Hofmann C; Ballhausen WG
Am J Ophthalmol; 2002 Jul; 134(1):147-8. PubMed ID: 12095833
[TBL] [Abstract][Full Text] [Related]
14. Development of a nude mouse model to study human sebaceous gland physiology and pathophysiology.
Petersen MJ; Zone JJ; Krueger GG
J Clin Invest; 1984 Oct; 74(4):1358-65. PubMed ID: 6237122
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemistry screening of sebaceous lesions for Muir-Torre syndrome in a 26-year period in a Mexican population.
Archer-Dubon C; Alvarez-Zavala B; Reyes E; Orozco-Topete R
Dermatol Online J; 2008 Dec; 14(12):1. PubMed ID: 19265614
[TBL] [Abstract][Full Text] [Related]
16. Muir-Torre Syndrome and founder mismatch repair gene mutations: A long gone historical genetic challenge.
Ponti G; Manfredini M; Tomasi A; Pellacani G
Gene; 2016 Sep; 589(2):127-32. PubMed ID: 26143115
[TBL] [Abstract][Full Text] [Related]
17. Muir-Torre syndrome - treatment with isotretinoin and interferon alpha-2a can prevent tumour development.
Graefe T; Wollina U; Schulz H; Burgdorf W
Dermatology; 2000; 200(4):331-3. PubMed ID: 10894967
[TBL] [Abstract][Full Text] [Related]
18. Muir-Torre syndrome.
Ponti G; Ponz de Leon M
Lancet Oncol; 2005 Dec; 6(12):980-7. PubMed ID: 16321766
[TBL] [Abstract][Full Text] [Related]
19. Microsatellite and genetic instability in patients with Muir-Torre syndrome.
Lorente-Lavirgen AI; Morillo-Andújar M; Zulueta-Dorado T; Conejo-Mir J
Actas Dermosifiliogr; 2013 Sep; 104(7):643-4. PubMed ID: 23891449
[No Abstract] [Full Text] [Related]
20. Widespread microsatellite instability in sebaceous tumours of patients with the Muir-Torre syndrome.
Peris K; Onorati MT; Keller G; Magrini F; Donati P; Muscardin L; Höfler H; Chimenti S
Br J Dermatol; 1997 Sep; 137(3):356-60. PubMed ID: 9349329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
